134 related articles for article (PubMed ID: 36936551)
1. Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study.
Shammas NW; Shammas G; Christensen L; Jones-Miller S;
Vasc Health Risk Manag; 2023; 19():133-137. PubMed ID: 36936551
[TBL] [Abstract][Full Text] [Related]
2. Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study.
Shammas NW; Purushottam B; Shammas WJ; Christensen L; Shammas G; Weakley D; Jones-Miller S;
Vasc Health Risk Manag; 2022; 18():603-615. PubMed ID: 35942041
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
4. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
Shammas NW; Jones-Miller S; Shammas GA; Shammas WJ
J Invasive Cardiol; 2020 Aug; 32(8):289-294. PubMed ID: 32737264
[TBL] [Abstract][Full Text] [Related]
5. JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.
Shammas NW; Petruzzi N; Henao S; Armstrong EJ; Shimshak T; Banerjee S; Latif F; Eaves B; Brothers T; Golzar J; Shammas GA; Jones-Miller S; Christensen L; Shammas WJ
J Endovasc Ther; 2021 Feb; 28(1):107-116. PubMed ID: 32885736
[TBL] [Abstract][Full Text] [Related]
6. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G
Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825
[TBL] [Abstract][Full Text] [Related]
9. 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon.
Sachar R; Soga Y; Ansari MM; Kozuki A; Lopez L; Brodmann M; Schroë H; Ramanath VS; Diaz-Cartelle J; Zeller T;
JACC Cardiovasc Interv; 2021 May; 14(10):1123-1133. PubMed ID: 34016410
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE Trial.
Steiner S; Schmidt A; Zeller T; Tepe G; Thieme M; Maiwald L; Schröder H; Euringer W; Popescu C; Brechtel K; Brucks S; Blessing E; Schuster J; Langhoff R; Schellong S; Weiss N; Beschorner U; Wittig T; Scheinert D
JACC Cardiovasc Interv; 2022 Oct; 15(20):2093-2102. PubMed ID: 36265942
[TBL] [Abstract][Full Text] [Related]
11. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
Radaideh Q; Shammas NW; Shammas WJ; Shammas GA
Cardiovasc Revasc Med; 2021 Jan; 22():66-70. PubMed ID: 32563711
[TBL] [Abstract][Full Text] [Related]
12. Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions (PHOTOPAC).
Böhme T; Noory E; Beschorner U; Lerke F; Schmidt A; Scheinert D; Ito W; Zeller T; Rastan A
Vasa; 2021 Sep; 50(5):387-393. PubMed ID: 34107772
[No Abstract] [Full Text] [Related]
13. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
14. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
15. Two-Year Outcomes of Endovascular Interventions of the Common Femoral Artery: A Retrospective Analysis From Two Medical Centers.
Shammas NW; Shammas GA; Karia R; Khalafallah R; Jones-Miller S; Shammas AN
Cardiovasc Revasc Med; 2021 Mar; 24():72-76. PubMed ID: 32921595
[TBL] [Abstract][Full Text] [Related]
16. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
[No Abstract] [Full Text] [Related]
17. Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions: The J-SUPREME and J-SUPREME II Trials.
Iida O; Urasawa K; Shibata Y; Yamamoto Y; Ando H; Fujihara M; Nakama T; Miyashita Y; Mori S; Diaz-Cartelle J; Soga Y
J Endovasc Ther; 2022 Apr; 29(2):240-247. PubMed ID: 34510954
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
19. Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty.
Soga Y; Iida O; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H
J Endovasc Ther; 2020 Dec; 27(6):946-955. PubMed ID: 32865145
[TBL] [Abstract][Full Text] [Related]
20. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
